All News

Cell Therapy

Oxford Biomedica Acquires ABL Europe from Institut Mérieux
6 December 2023
Oxford Biomedica Acquires ABL Europe from Institut Mérieux
Oxford Biomedica Acquires ABL Europe
20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry
4 December 2023
20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry
Lee Buckler, SVP Advanced Therapies,
FDA Investigating ‘Serious Risk’ of Secondary Malignancy Linked to BCMA- or CD19-Directed CAR-T Immunotherapies
29 November 2023
FDA Investigating ‘Serious Risk’ of Secondary Malignancy Linked to BCMA- or CD19-Directed CAR-T Immunotherapies
FDA investigates T cell malignancy
Revolutionizing Regenerative Medicine: Exploring the Promise and Challenges of Allogeneic Therapies
28 November 2023
Revolutionizing Regenerative Medicine: Exploring the Promise and Challenges of Allogeneic Therapies
David Sourdive joins us in
POPULAR NEWS ITEMS
Image
4 December 2023

20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry

Image
6 December 2023

Oxford Biomedica Acquires ABL Europe from Institut Mérieux

Image
5 December 2023

Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome

Navigating the Future of CGT Manufacturing: Exploring Challenges and Innovations in Manufacturing Science and Technology (MSAT)
28 November 2023
Navigating the Future of CGT Manufacturing: Exploring Challenges and Innovations in Manufacturing Science and Technology (MSAT)
In this interview David Sourdive
20 Years of Advanced Therapies with Stefanos Theoharis: Sticking with CGT Through Technical & Technological Advancement
27 November 2023
20 Years of Advanced Therapies with Stefanos Theoharis: Sticking with CGT Through Technical & Technological Advancement
Stefanos Theoharis, CBO, Kiji Therapeutics
20 Years of Advanced Therapies with Lindsey Clarke: a Community, Not Just a Conference
21 November 2023
20 Years of Advanced Therapies with Lindsey Clarke: a Community, Not Just a Conference
Lindsey Clarke, VP Commercial at
Applying Process Optimization and Process Intensification to Cell and Gene Therapy Manufacturing
16 November 2023
Applying Process Optimization and Process Intensification to Cell and Gene Therapy Manufacturing
This Q&A from Advanced Therapies
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry

Image

Oxford Biomedica Acquires ABL Europe from Institut Mérieux

Image

Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome